Pharmafile Logo

The Specials Laboratory

The Specials lab manufactures and supplies Specials drug tariff and non-tariffed unlicensed medicines (commonly known as ‘specials’) to community Pharmacists, Doctors, Vet Surgeons and Hospitals – within 24 hours. We provide hospitals with a space and time saving over labelling service, which involves the bespoke design and labelling of medicines. Once set-up, we store your over labelled products and deliver what you want, when you want – again, within 24 hours. And for hospitals, we also offer investigational medicinal product (IMP) manufacturing from our MHRA-licensed sites so we can meet the supply needs of hospital-based clinical trials.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

Unit 1 Regents Drive Low Prudhoe Industrial Estate, Prudhoe, Northumberland, NE42 6PX, United Kingdom
01661 831 811

 Latest Content from PMHub 

Cuttsy+Cuttsy becomes employee owned

Press Releases | February 9, 2026 | Cuttsy + Cuttsy

Cuttsy+Cuttsy announces its transition to employee ownership, celebrating 15 years of prioritising clients, patients, and its team while continuing under the leadership of founders Caroline Benson and Mathew Cutts.

New Webinar: 2026 Engagement Strategies For Modern Pharma

Press Releases | February 5, 2026 | Impetus Digital

Turn interaction into intelligence! Don’t miss this chance to lead the industry with our free pharma-exclusive webinar!

Why Sleep Health is the Missing Link in Women’s Wellness

Press Releases | February 5, 2026 | Medscape Education

While obstructive sleep apnea (OSA) affects approximately 32% of US adults—nearly 80 million people—it remains an "epidemic hiding in plain sight". Perhaps most staggering is that 90% of women with...

MFN Pricing Is Moving Fast – Here’s What Matters

With GENEROUS, GUARD, and GLOBE all released since December, 185 pages of policy will materially impact U.S. drug pricing — and yes, it's a lot to digest. In a new...

ISPOR’s 2026–2027 HEOR Trends report: The Era of Evidence Judgment

In response to ISPOR’s recently published 2026-2027 HEOR Trends, David Miller, CEO, Genesis Research Group, suggests that we’re no longer being evaluated on our ability to produce data, but on...

First impressions matter: Why getting your onboarding right is key for digital engagement

Press Releases | January 20, 2026 | Graphite Digital

As pharma organisations invest extensively in creating engaging content, the onboarding process must not be overlooked. Seamless onboarding is the key to ensuring that HCPs not only meet regulatory standards,...

How can pharma build genuine partnerships with patient communities?

Patient engagement is not optional in pharma – it’s integral. Meaningful partnerships with patients, caregivers and advocates must shape every stage of healthcare and medicines development, driving better outcomes, equity...

How will AI change field training?

Press Releases | January 15, 2026 | Inizio

Learn how a next-generation approach to field training – powered by GenAI and avatar simulations and enabled through Intelligent Commercialization™ – can transform field force effectiveness by delivering scalable, always-on,...

The Heart and Mouth Connection Every Woman Needs to Know

For decades, modern medicine has treated the mouth and the body as separate entities. But for Dr. Nieca Goldberg, a renowned cardiologist, and Dr. Maria Ryan, Chief Clinical Officer at...

Inizio Ignite Sparks a New Era of Connected Advisory Solutions

Press Releases | January 7, 2026 | Inizio

Inizio, a leading global commercialization partner for pharma and life sciences, today unveiled Inizio Ignite, a reimagined, fully integrated advisory partner designed to accelerate pharma performance through strategy, insights, and innovation.